Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring and maker of the #1 best-selling smart baby monitor,* announced the launch of the Owlet® Smart Thermometer, an FDA-registered, non-contact infrared forehead thermometer that delivers clinically accurate temperature readings in one second. The launch extends Owlet’s capabilities beyond sleep and overnight monitoring and into a product category found in nearly every home with children.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261110568256/en/

The Owlet Smart Thermometer captures forehead readings in just one second with an advanced infrared sensor. Use for quick temperature checks or sync to the Owlet Dream App via Bluetooth to log temperature history and trends, eliminating manual paper logs or typing in the dark.

The Owlet Smart Thermometer captures forehead readings in just one second with an advanced infrared sensor. Use for quick temperature checks or sync to the Owlet Dream App via Bluetooth to log temperature history and trends, eliminating manual paper logs or typing in the dark.

Available now in the U.S., the Owlet Smart Thermometer can be used as an everyday essential for quick temperature checks, no app required. Its no-touch infrared sensor takes a reading in one second without waking a sleeping child, with accuracy within ±0.4°F (±0.2°C). Caregivers who want a connected experience, or those who already use Owlet products including FDA-cleared Dream Sock®, can sync readings via Bluetooth to the Owlet Dream App. Parents with more than one child can set up separate profiles in the Owlet Dream App to log and view each child’s temperature history.

“Families come to Owlet for safety and peace of mind, and our job is to keep earning that trust as their needs evolve,” said Kurt Workman, Owlet’s President, Chief Executive Officer, and Co-Founder. “Our new Smart Thermometer is an important step in building a connected health platform that grows with the family. It brings Owlet into everyday health moments and puts clear, reliable information in parents’ hands when it matters most, whether they are an existing Owlet family or meeting us for the first time.”

A New Front Door to the Owlet Health Ecosystem

The Owlet Smart Thermometer is an everyday, high-frequency product at an accessible price, giving Owlet a new way to reach parents. It will be offered through Owlet’s website and, over time, through a growing mix of online and in-store retailers where parents already shop for everyday health essentials. For parents, it means a simple way to check and keep track of their child’s temperature at home, bringing the accuracy families expect from Owlet to one of the most routine parts of childcare.

Built on a Foundation of Trust in Pediatric Health

The Owlet Smart Thermometer joins a product lineup built with wellness and safety in mind. Dream Sock earned a De Novo FDA clearance in 2023, making it the first FDA-cleared smart baby monitor of its kind on the market. It also holds global certifications, including a CE mark across the UK and EU, as well as medical certification in Australia and New Zealand. BabySat® is the Company’s FDA-cleared prescription pulse oximeter for infants under physician care that is now being prescribed in all 50 states. Beyond products, Owlet launched its Baby Safety Task Force earlier this year to raise the standard for baby safety across the industry through education, innovation, and advocacy.

Owlet Smart Thermometer Highlights

  • Pricing: $49.99 MSRP
  • Launch Date and Retailers: Available now in the U.S. at www.owletcare.com, with several retail launches and international expansion planned.
  • Fast, Non-Contact Readings: Captures forehead readings in just one second with an advanced infrared sensor.
  • Clinically Accurate: FDA-registered and clinically accurate within ±0.4°F (±0.2°C), with a backlit LCD and on-device memory that stores up to 32 readings.
  • Standalone or Connected: Use for quick temperature checks, or sync to the Owlet Dream App via Bluetooth to log temperature history and trends, eliminating manual paper logs or typing in the dark.
  • Owlet Insights In One Home: Dream Sock users can see pulse rate, oxygen level, sleep data, and temperature readings all in one place for ease and total connectivity.

Black Friday & Cyber Monday Offers

In celebration of the holiday season, Owlet is offering its best sale of the year from November 15–30. During this promotional period, families can take $100 off Dream Sock and $100 off Dream Sock and Smart Thermometer bundle, and $110 off Dream Duo™, making it even easier for parents to access Owlet’s connected health solutions. Applicable offers are available at www.owletcare.com and select participating retailers nationwide, including Amazon, Target, Walmart, and Babylist.

About Owlet, Inc.

Owlet, Inc. (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors, delivering hospital-grade technology directly in the home. Our award-winning pediatric products and innovative software combine clinically tested monitoring systems, an integrated video platform, and a simple, easy-to-use app, providing parents with real-time health insights to stay informed on their child’s well-being, support restful sleep, and provide peace of mind anywhere. Since 2012, more than 2.5 million parents have trusted Owlet to monitor their children’s well-being and sleep. This adoption has fueled one of the largest collections of pediatric health and sleep data in the world, powering innovations that bridge the critical gap between hospital and home. Owlet is driving a new standard in pediatric wellness by pairing advanced medical technology with consumer-friendly design. Our mission is simple yet ambitious: to give every baby and every family the best possible start in life. Learn more at www.owletcare.com and follow us on LinkedIn and Instagram for company news and updates.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company’s anticipated commercial performance of the Smart Thermometer, plans to expand retail distribution and enter international markets; benefits of the Smart Thermometer and the Company’s connected health platform, future product offerings, and promotional activities. In some cases, you can identify forward-looking statements by terms such as “estimate,” “may,” “believes,” “plans,” “expects,” “anticipates,” “intends,” “goal,” “potential,” “continues,” “designed,” “seek,” “will,” the negation thereof, or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on the Company’s expectations at the time such statements are made, speak only as of the dates they are made, and are susceptible to a number of risks, uncertainties, and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. The Company’s actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by its forward-looking statements. Many important factors could affect the Company’s future results and cause those results to differ materially from those expressed in or implied by the Company’s forward-looking statements. Such factors include, but are not limited to: (i) the commercial success of Owlet’s products, including the Smart Thermometer and the Company’s subscription services, the market acceptance of new products, and the Company’s ability to attract new customers and cross-sell its products; (ii) the regulatory classification and status Owlet’s products, including Smart Thermometer, submissions to, actions taken by and decisions and responses from regulators, such as the FDA, the TGA and other similar regulators outside of the United States, as well as Owlet’s ability to obtain and maintain regulatory approval or certification for its products and comply with ongoing regulatory requirements; (iii) Owlet’s competition, including established thermometer and baby monitor companies, and the Company’s ability to profitably grow and manage growth; (iv) the ability of Owlet to implement strategic initiatives, reduce costs, grow revenues, develop and launch new products (including the timing of retail and international launches), innovate and enhance existing products, meet customer demands and adapt to changes in consumer preferences and retail trends; (v) Owlet’s ability to acquire, defend and protect its intellectual property and satisfy regulatory requirements concerning privacy, data protection and cybersecurity, including for Owlet’s digital platforms and technologies; (vi) Owlet’s ability to maintain relationships with, and secure placement through, retailers and other channel partners, and its reliance on third-party manufacturers and suppliers; (vii) impacts from compliance with applicable laws or regulations, including those related to consumer protection, promotions, subscriptions, and health-related products and services; (viii) the impact of and disruption to Owlet’s business, financial condition, operations, supply chain and logistics due to economic and other conditions beyond the Company’s control; (ix) adverse impacts from other economic, business, regulatory, competitive or other factors, such as changes in discretionary consumer spending and consumer preferences; (x) product quality, safety and liability risks, including product defects, recalls, inquiries or actions by governmental agencies or other regulators, and related costs, litigation, or reputational harm; (xi) the performance and availability of third-party platforms, services and products, and reputational or other risks arising from the actions, content, products, or services of third parties; and (xii) other risks and uncertainties set forth in the Company’s other releases, public statements and filings with the U.S. Securities and Exchange Commission (“SEC”), including those identified in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and as any such factors may be updated from time to time in the Company’s other filings with the SEC. All such forward-looking statements attributable to the Company or any person acting on the Company’s behalf are expressly qualified in their entirety by the cautionary statements contained or referred to above. Moreover, the Company operates in an evolving environment. New risk factors and uncertainties may emerge from time to time, and factors that the Company currently deems immaterial may become material, and it is impossible for the Company to predict such events or how they may affect Owlet. Except as required by law, the Company assumes no obligation to update any forward-looking statements after the date of this press release, whether because of new information, future events, or otherwise, although Owlet may do so from time to time. The Company does not endorse any projections regarding future performance that may be made by third parties.

*Circana, Consumer Electronics Store (CS) Channel, Dollar Share, 2026.

Media gallery

About The Author
Business Wire